๐ ็ธฝ็ฎ้ ๏ฝ ๐ ่ฑๆๅๆ๏ผๆฌ็ฏ๏ผ ๏ฝ ๐ ๅฎๆด็ฟป่ญฏ ๏ฝ โญ ็ฒพ่ฏ็ญ่จ
Bleeding
Bleeding
Bleeding is the most common post-Mohs surgery complication, and its risk is increased in patients taking anticoagulants. Still, there is no evidence that patients taking aspirin or warfarin for serious medical problems experience increased risks of serious hemorrhage or bleeding complications. Patients on thienopyridines such as clopidogrel or ticlopidine undergoing dermatologic surgery are, however, at increased risk of bleeding complications.44,45 These minor complications include partial necrosis in 1.7% of flap closures and 8.6% of graft closures (with no instances of complete necrosis or need for subsequent revision), and a 0.73% rate of dehiscence. Such complications are generally managed straightforwardly in the outpatient setting. Therefore, medically necessary anticoagulants are typically continued in the perioperative period in order to prevent thrombotic events.